## RL: Ralph Lauren Corporation - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -1.4% below STRENGTH zone (4.0-10.0%); PEG 2.12 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-5.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($342.37)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Zacks.com featured highlights include NVIDIA, Ralph Lauren, Expedia and Cencora**
- Source: The Globe and Mail | 20251223T154828 | Bullish | Relevance: 88%
- This article highlights four stocks—NVIDIA, Ralph Lauren, Expedia, and Cencora—trading near their 52-week highs, suggesting they have further upside potential. It explains that while investors often fear overvaluation at 52-week highs, strong fundamentals and momentum can drive continued growth. Each company's strong performance, future prospects, and analyst consensus estimates are detailed, making a case for why they are expected to keep scaling new highs.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Wells Fargo | $400 | $385 | +4% |
| 2025-12-12 | Jefferies | $425 | $385 | +10% |
| 2025-12-10 | Guggenheim | $0 | $0 | 0% |
| 2025-12-03 | Wells Fargo | $385 | $345 | +12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Wells Fargo | main | Overweight |
| 2025-12-12 | Jefferies | main | Buy |
| 2025-12-10 | Guggenheim | init | Neutral |
| 2025-12-03 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 9 ($0.00M) |
| Sells | 1 ($0.69M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.1%)
- Blackrock Inc.: 7.6% (-17.3%)
- JPMORGAN CHASE & CO: 4.6% (+75.3%)
- State Street Corpora: 3.8% (-4.2%)
- FMR, LLC: 3.4% (-12.8%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-5.5% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +9%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.12 elevated, pricing in significant growth expectations. Forward P/E 21.8x stretched relative to 8% growth. Quality metrics strong (ROE 34%). Balance sheet: strong liquidity (2.0x). Analyst sentiment positive (3 raises, avg +9%). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $22.0B |
| Beta | 1.53 |
| 52W Range | $176.61 - $380.00 |
| Short Interest | 5.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.12 |
| Forward P/E | 21.8 |
| Current P/E | 23.6 |
| YoY Growth | 8.3% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.1% to -1.4% (-5.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.4pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.25x) but short-term weakness (below SMA20). MACD histogram bearish (-1.27), momentum weakening. RSI neutral at 55. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.42% (CS: 38) | Neutral |
| RSI_14 | 54.7 | Neutral |
| MACD Histogram | -1.27 | Bearish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 1.058x | Above |
| vs SMA200 | 1.255x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $362.77
- **Stop Loss:** $342.37 (5.6% risk)
- **Target:** $383.17 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 44
- **Position Value:** $15,961.88
- **Portfolio %:** 15.96%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-05 (Est: $5.77)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.45 | $3.79 | +9.9% |
| 2025Q2 | $3.50 | $3.77 | +7.8% |
| 2025Q1 | $2.04 | $2.27 | +11.3% |
| 2024Q4 | $4.53 | $4.82 | +6.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*